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We investigated respiratory pathogens in a prospective cohort study
of young children living in the Peruvian Andes. In the study we
assessed viral respiratory infections among young children, and
explored interactions of viruses with common respiratory bacteria,
especially Streptococcus pneumoniae. Through weekly household visits,
data were collected on the signs and symptoms of acute respiratory
illness (ARI), nasal samples were collected to test for viruses during
episodes of ARI, and nasopharyngeal samples were collected on a
monthly basis to monitor bacterial colonisation. We also collected
data on vaccination coverage, patterns of social mixing, geographic
information, and environmental and socio-demographic variables.
Understanding the interaction of respiratory viruses with bacteria
and its impact on the burden and severity of ARIs in rural areas of
developing countries is critical to designing strategies for preventing
such infections. Investigators interested in more details about this
study or in accessing these resources should contact Dr. Carlos G.
Grijalva at Vanderbilt University (carlos.grijalva@vanderbilt.edu).
Keywords Epidemiology, acute respiratory illness, children, pneumococcus,
influenza
Why was the cohort set up?
Every year, children aged <5 years, regardless of their
country of residence or socio-economic status, have
from 3–6 episodes of acute respiratory illness (ARI).1
Pneumonia is the most serious ARI, accounting for
approximately 18% of all mortality in childhood3–5
with 95% of the deaths from this disease occurring
in the developing world.3,4
Although the precise reasons for the increased
severity of ARI in developing countries are unclear,
exposure to indoor air pollution is considered an im-
portant factor. In rural settings, cooking and heating
with solid fuels on open fires or stoves without
chimneys are common.6 According to the World
Health Organization (WHO), more than half of the
world’s population relies on dung, wood, crop
waste, or coal to meet basic energy needs.7 Indoor ex-
posure to smoke is thought to be responsible for
approximately 50% of all childhood pneumonia deaths
worldwide.7
Most severe pneumonias are caused by bacteria,
particularly Streptococcus pneumoniae,5 which often
colonizes the nasopharynx of children and is com-
monly transmitted from person to person.8 Although
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most nasopharyngeal colonization with S. pneumoniae
does not result in disease, the acquisition of a new
serotype is often associated with illness.8,9
Recent studies have focused on the potential
interaction between influenza virus and S. pneumoniae.
Colonization with pneumococci has seasonal patterns
similar to those of influenza,9 the incidence of
pneumococcal pneumonia increases during epidemics
of influenza,10,11 and influenza has been identified
in persons with pneumococcal pneumonia.12,13 A
secondary analysis of data from an efficacy trial of a
9-valent pneumococcal conjugate vaccine in South
African children examined pneumonia without
wheezing as an outcome. The incidence of influ-
enza-associated pneumonia was reduced by 45% in
subjects vaccinated with the pneumococcal conjugate
as compared with that in controls.14 This decline was
observed only among children infected with human
immunodeficiency virus (HIV), and reductions were
also observed for pneumonia associated with non-in-
fluenza viruses.14,15 However, a similar randomized
trial of an 11-valent pneumococcal-conjugate vaccine
in the Philippines (mainly in non-HIV-infected chil-
dren), which included all pneumonias, failed to rep-
licate these observations.16 Experimental infection of
animals with pneumococcus after influenza infection
results in more severe disease than that caused by
either pathogen alone.17–20 It is not clear whether fac-
tors common to both pathogens (i.e. neuraminid-
ase)18,19 and/or other immunological host factors
(e.g. interferon-gamma)21 mediate this interaction. It
has also been found that infection of ferrets with in-
fluenza A virus increased the transmission of certain
pneumococcal serotypes.22 Although studies have
failed to demonstrate that influenza increases
pneumococcal colonization in adult humans,23 similar
studies have not been conducted in children.
Understanding pneumococcal colonization patterns
in rural communities of developing countries is cru-
cial for implementing effective strategies for prevent-
ing pneumococcal pneumonia. Early pneumococcal
colonization has resulted in a lower vaccine-associated
antibody response to colonizing serotypes.24-26
Nevertheless, the clinical relevance of these findings
in settings with high pneumococcal colonization re-
mains unknown.
The present study will provide information about
the distribution of colonizing bacteria, especially
S. pneumoniae, the role of respiratory viruses in
pneumococcal colonization, and the impact of other
environmental factors, such as indoor smoke expos-
ure, on bacterial colonization and the incidence and
severity of ARIs among young Andean children.
How is it funded?
The study is supported in part by a Clinical and
Translational Science Awards (CTSA) grant to
Vanderbilt University from the US National
Institutes of Health (NIH), an investigator-initiated
research grant from Pfizer, and a grant from the
Thrasher Research Fund. The study protocol was
approved by the Vanderbilt Institutional Review
Board (Nashville, TN, USA), and by the Ethics
Committee of the Instituto de Investigacion
Nutricional, IIN (Lima, Peru). The study was imple-
mented in communities that participated in a com-
munity-cluster randomized trial, that evaluated an
integrated home-based intervention package described
below. It was conducted by the IIN and the Swiss
Tropical and Public Health Institute, in Basel,
Switzerland and supported by the UBS Optimus
Foundation.27
Who is in the cohort?
The study was conducted in the Province of San
Marcos, Department of Cajamarca, located in the
northern highlands of Peru. Cajamarca has a popula-
tion of about 1.5 million, is 2700 m above sea level,
and has a dry and sunny equatorial climate. San
Marcos, in southeastern Cajamarca, includes areas
ranging from approximately 1500–4000 m above sea
level. Nearly all inhabits of San Marcos are descended
from the same ethnic group of Spanish people who
mixed with the local Quechua population. The popu-
lation is primarily rural, with low income, low educa-
tional level, and limited access to health-care services;
74% of the population is poor. San Marcos has a
United Nations Development Program (UNDP)
Human Development Index of 0.553, which ranks it
in the 20th percentile of Peru. In 2007, the average
life expectancy in San Marcos was 70 years, and 76%
of the inhabitants were able to read and write. The
median per-capita income per month in 2007 was
US$71, ranking San Marcos in the 36th percentile
for Peru.28
Investigators obtained approvals from each local
community in the study area. Field activities began
with a local census to enumerate all families and to
identify potential participants. Trained field workers
visited all houses and interviewed family members,
using a standardized census form. These activities
provided basic demographic information about the
population in the study area, composition of the
households, and number of children eligible for
enrollment in the study.
To assure a representative sample of the commu-
nities in the study area, broad selection criteria were
used for enrollment, consisting of: (i) families with
children aged <3 years (including newborns); and
(ii) intention to remain in the study area for the
next year.
Identified households with potentially eligible
children were visited and, after informed consent
was obtained, children were enrolled and follow-up
was begun. At enrollment, field workers obtained
demographic and socio-economic information and
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data on health-services utilization and risk factors for
ARI, including vaccination history. Consent was ob-
tained to access participants’ medical and vaccination
records for the duration of their participation.
During 2008–2009, before the study began, a com-
munity-cluster randomized trial conducted in the
study area assessed the effects of an integrated
home-based intervention package on clinical out-
comes (without assessments of disease etiology).27
In that trial, communities were randomly allocated
to either psychomotor stimulation of their children
(control arm) or provision of an improved stove (to
reduce indoor smoke) and sink, solar disinfection of
water, and information about kitchen hygiene (inter-
vention arm). A subset of eligible households that
participated in the randomized trial was invited to
participate in our prospective cohort study to assess
the effects of reduced indoor exposure on pneumococ-
cal colonization and the incidence of viral ARIs.
From May 2009 through September 2011, 892 chil-
dren were enrolled in the study with the aim of main-
taining a dynamic cohort with approximately 500
children under observation at any one time. Of 403
children enrolled in the randomized trial who were
invited to participate in our observational study, 272
(67.5%) agreed to participate and were enrolled in this
study, accounting for 30% of the total cohort (Figure 1).
The median age of enrolled children was 4.6
months, and 52% of the children were male. The
median number of people living in study households
was 5, and the materials of which the houses were
predominantly made were typical of rural Andean set-
tings, including dirt floors, tile roofs, and mud brick
walls. Most houses used open fires or traditional
stoves and wood for cooking. Most of the children
(91%) in the study received health care though the
public health insurance system of Peru (Table 1).
During follow-up, 126 children (14%) were with-
drawn from the study by their parents (Table 2). As
compared with children who were not withdrawn,
those who were withdrawn from the study were
older at enrollment (median age 9 months vs. 3
months, respectively, P< 0.001), less likely to use
traditional stoves or open fires for cooking (52% vs.
63% respectively, P< 0.001), and less likely to have
vaccination cards available (90% vs. 94%, respectively,
P¼ 0.011). However, there were no differences in sex,
maternal education level, number of people living in
the household, or enrollment in the public health
insurance system between children who were and
were not withdrawn.
How often have they been
followed up?
Trained field workers visited each household weekly
to collect information on ARI through the use of a
standardized questionnaire. Field workers were
trained to recognize respiratory signs and symptoms
Figure 1 Composition of study cohort
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by using educational material prepared by the Pan
American (World) Health Organization in the
Integrated Management of Childhood Illnesses
(IMCI)–WHO.29-31 Weekly household visits allowed
timely sampling of information about ARI and max-
imized the probability of detection of respiratory
viruses while minimizing recall bias.32
Follow-up for each child continued from enrollment
through the first of: (i) attainment of the age of 3
years; (ii) withdrawal of consent; (iii) loss to follow-
up (travel outside the area or inability to locate); (iv)
death; or (v) the end of the study (September 30,
2011). We maintained a relatively stable cohort size
by enrolling additional newborns throughout the
study. The reasons for loss to follow-up are listed in
Table 2.
A physician was available for children with compli-
cated ARIs, defined by the presence of WHO–IMCI
danger signs (e.g. tachypnea, chest retractions,
etc.).29–31 Cell phones allowed prompt communication
between field workers and study headquarters for
immediate feedback and to summon the physician
to evaluate children with complicated ARIs.
What has been measured?
Acute respiratory infections
At each weekly visit, field workers recorded children’s
respiratory signs and symptoms for the preceding 7
days, enabling day-by-day reconstruction of episodes
of ARI (Figure 2). If a child had cough or fever at the
time of the visit or the previous day, WHO-IMCI
danger signs were assessed (Figure 3). Surveillance
forms similar to those used for this purpose had
been used in other limited-resource settings and
Table 1 Selected baseline characteristics of enrolled children (N¼ 892)
Demographics
Age in months, median (IQR) 4.6 (0.5, 17.1)
Male 52%
Socioeconomic characteristics
Number of people living in household, median (IQR) 5 (4, 6)
Number of children <5 years old in household, median (IQR) 1 (1, 2)
Number of bedrooms in house, median (IQR) 1 (1, 2)
Number of rooms (excluding bedrooms) in house, median (IQR) 2 (1, 3)
At least one family member attending school 54%
Family owns house 68%
House floor: dirt 91%
House roof: tile 93%
House walls: mud bricks 93%
Water supply: pipeline 82%
Sewage: connected to public system 9%
House energy: electricity 40%
House kitchen: open fire/traditional stove 63%
Energy for stoves: wood 93%
Smoking in house 8%
Children taken to weekend public markets 65%
Father: works in agriculture 64%
Mother: elementary education or less 65%
Health care related characteristics
Children enrolled in public health insurance system 91%
Children had vaccination card available 93%
IQR, interquartile range
Table 2 Reasons for ending follow-up
End of study (September 30 2011) 459 (51.4%)
Reached 3 years of age 246 (27.6%)
Consent withdrawn 126 (14.1%)
Moved outside area/unable to locate 56 (6.3%)
Death 5 (0.6%)
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were shown to be valid tools for identifying pneumo-
nia.32 Field workers were trained in the use of the
forms, a comprehensive field-procedures manual
including support algorithms for the coding of forms
was developed, and regular group meetings were held
for the review of forms.
Field supervisors prepared visit schedules; reviewed
study forms at the end of each day for data complete-
ness; and assured prompt delivery of samples to the
laboratory. Incomplete forms or inconsistent informa-
tion necessitated return of the field worker or super-
visor to the household. Furthermore, supervisors
performed audits of a random subset of households
to confirm the accuracy of the data collected. At the
computer centre established in San Marcos, data from
the study forms and collected samples were double
entered by trained personnel. Weekly checks were
done for data completeness and consistency.
Respiratory samples
Field workers were trained in standard procedures for
collecting and transporting samples. The collection of
nasal swabs followed procedures previously
reported.33,34 In brief, one swab was placed into
each nostril sequentially and rotated beneath the tur-
binates to collect epithelial cells and absorb secretions.
The swab was then inserted into a tube with Remel
M4RT viral transport medium and transported in
envelopes with cold packs to the local research labora-
tory in San Marcos within 8 hours of sample collec-
tion. At the local research laboratory, two 800-ml
aliquots were preserved as original samples and
three 200-ml aliquots were preserved in lysis cryovials
with 300-ml lysis buffer (MagNA Pure LC, Roche,
Indianapolis, IN and MagMAX, Ambion, Grand
Island, NY). All vials were labeled and stored at –
708C in the local research laboratory. Samples were
sent to Vanderbilt University for identification of
influenza viruses, respiratory syncytial virus, human
metapneumovirus, rhinovirus, adenovirus, and para-
influenza viruses through real-time reverse transcrip-
tion–polymerase chain reaction (RT–PCR) as
previously described.34–37
Nasopharyngeal samples, collected monthly whether
or not respiratory symptoms were present, and during
complicated ARIs, were obtained according to WHO
recommendations for identifying pneumococcal colon-
ization.38 In brief, samples were collected with a deep
nasopharyngeal Rayon polyester swab, and were im-
mediately placed in a tube with 1 ml of transport
medium (skim milk–tryptone–glucose–glycerine
(STGG). The specimens were transported in envelopes
with cold packs to the local laboratory within 8 hours
of collection. Specimens were preserved with the swab
in the medium at –708C. Samples were sent to Emory
University for identification of colonizing bacteria
including S. pneumoniae, H. influenzae, and S. aureus.
Laboratory studies included bacterial culture, pheno-
typic identification, molecular detection and quantifi-
cation of bacterial load through quantitative PCR
(qPCR), and pneumococcal serotyping through multi-
plex PCR as previously reported.39–41
Nasal swabs were collected for each new episode of
ARI, defined as cough or fever present within the pre-
vious 7 days, including the visit date. Nasal swabs were
not collected in consecutive weeks unless new mani-
festations of a complicated ARI developed. Thus, our
approach considered a minimum 7-day window period
to separate episodes of ARI. Detailed procedure man-
uals were provided to field workers. The flow of activ-
ities and the corresponding sample collection algorithm
for field workers are shown in Figures 2 and 3.
Social contacts
Contact patterns are considered important determin-
ants of the transmission of ARI.42 During designated
Figure 2 Household visits and respiratory sample collection strategy
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visits by field workers, members of selected house-
holds were invited to record all contacts experienced
from 6 am of the previous day through 6 am of the
day of the recording. Contact information for children
was provided by their parents. Field workers used a
structured questionnaire previously used for assess-
ments of social contacts in Europe42 and adapted
after field-testing. For this assessment, a contact
was classified as physical contact [skin-to-skin con-
tact (i.e. a kiss or handshake)] or non-physical con-
tact (conversation with another person who is
physically present but with whom there is no skin-
to-skin contact). Participants also provided informa-
tion about the sex and age of the contact person(s).
Each contact was further characterized by location,
duration, and the estimated frequency of similar
contacts.42 Collection of contact assessment data was
completed between August and October 2011. A total
of 114 families were included in this assessment, and
contact questionnaires were completed for 96% of 588
eligible household members.
What has been found? Key
findings and publications
From May 2009–September 2011, a total of 55 661
household visits were scheduled, 89% were executed
(i.e. field workers reached their target households),
and 79% were successfully completed (i.e. information
was collected during the visit). A total of 4655 nasal
and 10 722 nasopharyngeal swabs were collected.
Figure 3 Algorithm for ARI assessment and sample collection. NP, nasopharyngeal
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Collection of nasopharyngeal swabs was completed in
88% of scheduled collections.
During follow-up, there were 319 476 child-days of
observation and an estimated incidence of ARI of 5
episodes per child-year. The median duration of epi-
sodes of ARI was 5 days, and approximately 1 in 12
ARIs present at the time of the household visit were
complicated by the presence of WHO–IMCI danger
signs. During episodes of ARI, cough (76%), fever
(70%), and rhinorrhea (74%) were commonly present.
Approximately 25% of episodes of ARI resulted in
health care encounters and 1% resulted in hospital-
ization. Overall, 33% of children enrolled in the study
received at least one dose of influenza vaccine and
62% received at least one dose of pneumococcal con-
jugate vaccine (Table 3).
We also assessed the performance of qPCR relative
to traditional bacterial culture for detecting colonizing
S. pneumoniae, H. influenzae, and S. aureus in 446 naso-
pharyngeal samples collected from 360 healthy chil-
dren during 2009. Concurrent bacterial colonization
involving these 3 bacteria was also studied.
Quantitative PCR detected more bacteria than did cul-
ture. A comparison of the results of culture and qPCR
showed that 60.1% and 77.4%, respectively, of the
swabs with the two techniques were positive for
S. pneumoniae, 23.6% and 37.3% were positive for
H. influenzae, and 11.9% and 40.8% were positive for
S. aureus. There was a positive association between
colonization with S. pneumoniae and H. influenzae
both with culture (odds ratio [OR] 3.11) and qPCR
(OR 1.95). The densities of S. pneumoniae and H. influ-
enzae, as measured with qPCR, were positively correlated
with one another (r¼ 0.32). A negative association was
found between the presence of S. pneumoniae and that of
S. aureus with both culture (OR 0.45) and qPCR (OR
0.61). Quantitative PCR improved the yield of nasophar-
yngeal samples from young children, especially at a
density of <104 colony forming units (CFU)/ml, where
culture was poorly sensitive. The effect of bacterial dens-
ity on detection by culture, and the observed density-
related interactions, support the use of qPCR in subse-
quent studies of ARI.43
What are the main strengths and
weaknesses?
Strengths
Populations living in rural high-altitude communities
other than those in San Marcos have characteristics
similar to those of our study population, and the re-
sults of our study would be informative for those
settings. Even though vaccination with influenza
and pneumococcal conjugate vaccines is routine in
the developed world, the long-term sustainability of
routine vaccination with either or both of these vac-
cines is unclear in many developing countries. Our
study will provide information on the preventive po-
tential of these vaccines and will allow quantification
of the effects of pneumococcal conjugate vaccines in
preventing colonization in these settings.
In developing countries, access to health care is
often limited by poverty or cultural barriers. In these
settings, traditional studies based at health care cen-
tres might select relatively sicker or wealthier children
and may not accurately assess the true disease burden
in a particular area. Our study avoids these issues by
using weekly household visits to assure a systematic
and comprehensive assessment of all episodes of ARI.
Weaknesses
A limitation of our study is the lack of radiologic
equipment in the study communities for identifying
pneumonia. Such equipment is costly to acquire and
maintain. Nevertheless, our study is designed to
reflect the reality of numerous rural populations in
which access to health care and radiologic examin-
ation is limited. We therefore followed WHO
recommendations (i.e. IMCI–WHO protocols) for
recognizing major causes of childhood disease in
these settings.29–31 Although our field workers were
trained in the assessment of respiratory signs and
symptoms based on these protocols, some measure-
ments may be subject to misclassification.
Another limitation of the study is the potential
recall bias introduced during data collection.
Although we performed intensive surveillance
through weekly household visits, some studies have
used more frequent home visits (e.g. twice per week
or daily) in attempts to minimize recall issues.
Table 3 Follow-up measurements
ARI incidence
Total child-days of observation 319 476
Number of ARIs 4635
Incidence of ARI per child-year 5
ARI symptoms
Cough 76%
Fever 70%
Rhinorrhea 74%
Complicated ARI
Household visits with ARIs
present at the visit or previous day
2535
IMCI–WHO danger signs present 208
Percent with complicated ARI 8%
Health care encounters
Health care encounters with ARI 25%
Hospitalizations with ARI 1%
Vaccination
At least one dose of influenza vaccine 33%
At least one dose of
pneumococcal conjugate vaccine
62%
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We considered using those alternatives, but they
required a substantial increase in resources, making
them prohibitive. Alternative surveillance visits made
every 2 weeks may be affected by recall issues.32,44
Although influenza and pneumococcal conjugate
vaccines were incorporated into the Peruvian infant
vaccination schedule in 2009, routine vaccination
has not been uniformly implemented in Peru.
Vaccination with pneumococcal conjugate vaccine
will have an effect on colonization with vaccine sero-
types, and as vaccination coverage increases, our abil-
ity to assess the interaction between respiratory
viruses and specific pneumococcal vaccine serotypes
may be limited. Nevertheless, our study will allow
us to assess the progressive use and timing of vaccin-
ation with influenza and pneumococcal conjugate
vaccines, and the effects of the vaccination programs
on pneumococcal colonization in this rural
population.
Despite intensive weekly surveillance, our study may
have missed some episodes of ARI. Parents sometimes
took their sick children directly to the health care
centre before the scheduled study visit, and did so
without notifying the study personnel. Accordingly,
we reviewed medical records of these enrollees to cap-
ture the relevant episodes of ARI, but were unable to
collect specimens for microbial testing.
Although our project focused on the major respira-
tory pathogens, the relevance of other micro-organ-
isms to public health is increasingly recognized.
Additional resources will be needed to study other
pathogens. Sample aliquots collected in our study
will be preserved for future evaluations.
Can I get hold of the data? Where
can I find out more?
We welcome initiatives to further explore the data
made available by our study and/or to combine our
data with other resources for additional studies.
Investigators interested in more details about this
study, or in accessing these resources, should contact
Dr Carlos G. Grijalva at Vanderbilt University
(carlos.grijalva@vanderbilt.edu).
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KEY MESSAGES
 Young Andean children had an average of 5 ARI episodes per year. This incidence is similar to the 3-6
ARIs per year usually described for children aged <5 years without regard to country of residency or
socioeconomic status.
 Approximately 1 in 12 children with an ARI present at the time of the household visit had ‘danger
signs’ of severe disease [according to definitions from the World Health Organization-Integrated
Management of Childhood Illnesses (WHO-IMCI)].
 Over 75% of children carried Streptococcus pneumoniae in their nasopharynx.
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